Acquisition valued at US$2.2 billion expands company's presence in Canada.
Latest In Pharmaceutical & Health Care
Both companies will become part of McKessons specialty health business.
Pharmaceutical segment sales increased 25 percent year-over-year.
Bustling M&A activity sees transactions across 12 industry sectors.
Fourth quarter sales increase 12.3 percent year-over-year.
Industrial sales for the diversified manufacturer decreased 7.1 percent.
CEO: $2.6 billion acquisition expands company's "innovative service offerings for health systems."
Acquisition includes UDGs pharmaceutical distribution, home health care and travel health care divisions.
W. Marshall Simpson rejoins Owens & Minor in a new role.
Fiscal fourth-quarter sales up 20 percent year-over-year.
Sales for the first six months increased 5.5 percent year-over-year.